
U.S. FDA LABELING & REGULATORY COMPLIANCE
FDA Compliant Labels: Nutrition Facts, Supplement Facts, Drug Facts and Misbranding Risks
Product labeling is one of the most visible—and most frequently scrutinized—parts of U.S. Food and Drug Administration compliance. A product can be properly manufactured, properly imported and associated with a registered establishment, yet still face enforcement problems if its label, package, website, advertising-related labeling or claims create a false or misleading impression.
For domestic manufacturers and for European, Asian, Latin American and African businesses exporting FDA-regulated products to the United States, label compliance should therefore be treated as a core part of the U.S. market-entry strategy rather than as a final graphic-design exercise.
Introduction
Why FDA-Compliant Labeling Matters
A product label is much more than a marketing surface. Under U.S. law, it can communicate a product's identity, quantity, ingredients, nutritional composition, active ingredients, intended use, directions, warnings, manufacturer or distributor information and other material facts needed by consumers, healthcare professionals, importers and regulators.
Depending on the product category, FDA labeling requirements can be highly specific. A conventional packaged food may require a Nutrition Facts panel. A dietary supplement generally uses a Supplement Facts panel. A nonprescription drug commonly requires a standardized Drug Facts panel. Cosmetics, medical devices and other FDA-regulated products have their own applicable labeling requirements.
Errors are not limited to missing text. A label may become problematic because information is placed incorrectly, lacks required prominence, uses an inappropriate serving size, omits an ingredient or allergen, includes unauthorized disease claims, fails to provide warnings, uses misleading graphics, mischaracterizes an FDA registration or displays language suggesting FDA endorsement.
This is particularly important for foreign manufacturers. A label that is acceptable in France, Italy, Germany, Spain, China, Japan, South Korea, India, Brazil, Mexico, Colombia, South Africa or another market does not automatically satisfy U.S. requirements. The American regulatory classification and presentation rules must be considered independently.
A label can change the regulatory identity of a product
Intended use is critically important. Claims appearing on packaging, websites, social media, brochures and other labeling materials can influence whether FDA views a product as a conventional food, dietary supplement, cosmetic, drug or another regulated category.
Chapter 1
What Does “FDA Compliant Label” Mean?
There is no universal label format covering every FDA-regulated product. Compliance depends first on properly identifying what the product legally is and which regulatory framework applies.
Correct Identity
Determine whether the article is a conventional food, dietary supplement, OTC drug, prescription drug, cosmetic, medical device or another regulated product.
Required Information
Include the statements, panels, ingredient declarations, warnings, directions, business information and quantity declarations required for the product category.
Proper Presentation
Required information must appear with appropriate placement, prominence, legibility, terminology and formatting.
Truthful Claims
Statements must be truthful, appropriately substantiated and consistent with the regulatory status of the product.
Material facts matter
Labeling can be misleading not only because of what it expressly says, but also because of what it fails to reveal. Material information may be necessary to prevent other representations from becoming misleading or to communicate consequences associated with ordinary or labeled conditions of use.
Chapter 2
The FDA Logo, Registration Numbers and False Impressions of Approval
The FDA logo is an official government identifier. Private businesses should not place the FDA logo on commercial labels, certificates, websites, sales presentations or marketing materials in a manner that suggests FDA endorses a private company, product or service.
This is particularly relevant to exporters and manufacturers that receive confirmation of establishment registration. Companies sometimes incorrectly convert a registration acknowledgment into a commercial “FDA Certificate” or display an FDA-style seal on a product package.
Registration serves a regulatory or administrative purpose. It does not, by itself, transform a product into an FDA-approved product.
Avoid Claims Such As
- “FDA Certified” when no such certification applies.
- “FDA Approved Facility” merely because a facility is registered.
- “Approved by the U.S. FDA” for a dietary supplement simply because it is marketed in the United States.
- FDA-style seals or graphics implying government endorsement.
- Marketing a registration number as proof that FDA has approved product safety or effectiveness.
FDA registration and FDA approval are different concepts
Some categories of products undergo specific FDA premarket review or approval processes. Other categories do not. A company should accurately describe the regulatory status applicable to its product rather than using “FDA approved” as a general marketing expression.
Chapter 3
Nutrition Facts Labels for Conventional Foods
The Nutrition Facts label is required on most packaged conventional foods and beverages, subject to applicable exemptions and special rules. It provides standardized nutritional information that helps consumers compare products and understand the nutrient content of a serving.
A compliant Nutrition Facts panel involves much more than calculating calories. Manufacturers must evaluate the appropriate serving size, servings per container, nutrient declarations, Daily Values, rounding rules, measurement units and format.
Serving Information
Serving size and servings per container are foundational because nutrient values are generally declared in relation to the serving.
Calories & Nutrients
The panel communicates calories and required nutrient amounts using prescribed units and formatting.
Percent Daily Value
% Daily Value helps consumers understand how a nutrient in one serving contributes to a total daily diet.
Examples of Current Daily Values
Saturated Fat
20 g = 100% DV
Sodium
2,300 mg = 100% DV
Dietary Fiber
28 g = 100% DV
Added Sugars
50 g = 100% DV
Vitamin D
20 mcg = 100% DV
Calcium
1,300 mg = 100% DV
Iron
18 mg = 100% DV
Potassium
4,700 mg = 100% DV
Imported foods may present additional practical challenges because nutrient information is often originally calculated under European Union, Canadian, Asian or other national standards. The manufacturer should not simply resize or translate the foreign nutrition panel. U.S. serving-size rules, units, nutrients, Daily Values and formatting should be separately evaluated.
Chapter 4
Major Food Allergens and Ingredient Declarations
Ingredient and allergen declarations are among the most important food-labeling compliance areas. A packaged food can be misbranded if required allergen information is omitted or improperly declared.
The nine major food allergens under U.S. federal law are:
Milk
Including ingredients derived from milk when allergen declaration requirements apply.
Eggs
Egg-derived ingredients require appropriate consideration in allergen labeling.
Fish
The specific species, such as bass, flounder or cod, may need to be identified.
Crustacean Shellfish
Examples include shrimp, crab and lobster.
Tree Nuts
Examples include almonds, walnuts and pecans, with the specific nut identified as applicable.
Peanuts
Peanut ingredients must be appropriately declared when present.
Wheat
Wheat is a major food allergen requiring appropriate labeling when applicable.
Soybeans
Soy ingredients must be evaluated for applicable allergen declaration requirements.
Sesame
Sesame became the ninth major food allergen effective January 1, 2023.
Manufacturers should also evaluate the ingredient statement for common or usual names, ingredient order, subingredients, colors, flavors, preservatives and other required declarations. The recipe, specification sheets and finished artwork should agree with each other.
Chapter 5
Supplement Facts Labels for Dietary Supplements
Dietary supplements use a Supplement Facts panel rather than the conventional Nutrition Facts panel. Dietary supplements can include vitamins, minerals, herbs, botanicals, amino acids and other qualifying dietary ingredients.
The Supplement Facts panel generally identifies the serving size, servings per container, dietary ingredients, quantitative amounts and applicable percentages of Daily Value. Ingredients not declared within the Supplement Facts panel are generally addressed in the other-ingredients statement as applicable.
Important Differences from Nutrition Facts
Dietary Ingredients
Dietary ingredients without established Daily Values may be listed in the Supplement Facts panel when appropriate, while the Nutrition Facts framework is structured differently.
Ingredient Sources
A dietary ingredient source can in appropriate circumstances be identified within a Supplement Facts panel.
Botanical Ingredients
Botanical dietary ingredients require careful identification, including applicable plant-part information.
Other Ingredients
Ingredients not declared as dietary ingredients within the Supplement Facts panel generally must be appropriately addressed in the other-ingredients declaration.
Chapter 6
Disease Claims: Where Supplements and Foods Can Become Drugs
One of the most significant labeling risks for dietary supplements and conventional foods involves disease claims. As a general regulatory principle, a dietary supplement is not lawfully marketed as a product intended to diagnose, treat, cure or prevent disease. Products intended for these purposes are subject to drug requirements.
This distinction can be misunderstood because dietary supplements may use certain permissible types of claims. Depending on the circumstances and applicable requirements, these can include nutrient-content claims, authorized or qualified health claims, and structure/function claims.
Nutrient Content Claims
These characterize the level of a nutrient or dietary substance, such as claims involving “high,” “low,” “free” or similar regulated terms when applicable requirements are satisfied.
Health Claims
These describe a relationship between a substance and reduction of disease or health-related-condition risk and are subject to specific FDA regulatory frameworks.
Structure/Function Claims
These may describe how a nutrient or dietary ingredient affects or maintains the normal structure or function of the human body, subject to applicable requirements.
Website and social-media claims matter too
Compliance review should not stop at the printed package. Product pages, brochures, testimonials, marketplace listings and social-media statements can provide evidence of intended use. A conservative package label does not necessarily eliminate risk if surrounding promotional materials describe the product as treating or preventing disease.
When structure/function or certain related claims are made for a dietary supplement, applicable law requires specific procedures and the familiar disclaimer explaining that FDA has not evaluated the claim and that the product is not intended to diagnose, treat, cure or prevent any disease.
The wording should not be treated as a magic disclaimer that cures an otherwise unlawful disease claim. The overall message conveyed by the product presentation must remain consistent with the legal status of a dietary supplement.
Chapter 7
Drug Facts Labels for OTC Drug Products
Nonprescription or over-the-counter drug products generally use the standardized Drug Facts format. Common consumer products can fall within OTC drug regulation even when buyers do not initially think of them as medicines.
Examples can include sunscreen drug products, certain anti-dandruff products, fluoride anticaries products, antiperspirants, certain skin protectants, cough and cold products, laxatives and other products marketed for recognized therapeutic uses.
An OTC Drug Facts label is designed to present essential information in a consistent format so consumers can understand what the active ingredient does, why the product is used, when it should not be used and how it should be administered.
Active Ingredient
Identifies the drug's active ingredient and its applicable amount or concentration.
Purpose
Identifies the pharmacological or therapeutic category or function of the active ingredient.
Uses
States the indications or uses appropriate for the OTC drug under its applicable regulatory framework.
Warnings
Communicates circumstances when the product should not be used and other required safety information.
Directions
Explains how much product to use, how to use it and how frequently it may be used.
Other Information
Can address storage conditions and other applicable information, with inactive ingredients declared separately as required.
Foreign manufacturers should be particularly careful when translating an OTC label. The United States does not necessarily permit the same active ingredients, concentrations, indications, warnings or dosage instructions used in another country. Translation alone is therefore not sufficient to establish FDA compliance.
Chapter 8
Cosmetics, OTC Cosmetics and Therapeutic Claims
Cosmetic companies frequently encounter classification problems because marketing departments understandably want powerful claims. However, a conventional cosmetic is generally intended for cleansing, beautifying, promoting attractiveness or altering appearance rather than treating disease or producing therapeutic effects that make the product a drug.
Claims involving acne treatment, dandruff treatment, hair restoration, therapeutic eyelash growth or other disease or body-structure effects may cause a product marketed as a cosmetic to fall within drug regulation, depending on the facts and intended use.
Conventional Cosmetic Positioning
- Cleansing.
- Beautifying.
- Promoting attractiveness.
- Changing appearance.
Potential Drug Positioning
- Treating or preventing disease.
- Therapeutic acne claims.
- Dandruff-treatment claims.
- Claims intended to affect body structure or function in a drug-related manner.
Some products are both cosmetics and drugs. An anti-dandruff shampoo, for example, can have cosmetic functions associated with cleansing hair while also making drug claims associated with controlling dandruff. Such products must satisfy the requirements applicable to each relevant regulatory category.
Chapter 9
Misleading Labels and Failure to Reveal Material Facts
Misbranding does not arise only when a company prints an obviously false statement. Under the Federal Food, Drug, and Cosmetic Act and applicable regulations, the complete impression created by labeling can matter.
When evaluating whether labeling is misleading, regulators may consider representations made or suggested through words, statements, designs, devices and combinations of those elements. They may also consider whether the labeling fails to disclose material information.
Missing Warnings
A safety warning may be material when consumers need that information for safe use of a product.
Misleading Claims
A technically true statement can still create problems if the overall context gives consumers an inaccurate impression.
Omitted Information
Failing to disclose information needed to understand another claim or consequence of use can contribute to misleading labeling.
Graphic design is therefore part of regulatory compliance. Font size, placement, contrast, terminology, claim prominence, images and nearby statements can affect what consumers understand from a package.
Chapter 10
Label Compliance for Foreign Manufacturers and Exporters
International businesses shipping products to the United States often face a dual compliance challenge: the product itself must satisfy applicable U.S. requirements, and the label must communicate the required information in the form expected in the American marketplace.
European Companies
EU nutrition declarations, ingredient terminology and claims frameworks should not automatically be carried over to U.S. packaging.
Asian Companies
Translation, ingredient names, serving information, botanical terminology and therapeutic positioning may require U.S.-specific review.
Latin American Companies
Spanish or Portuguese packaging intended for export may need revised English labeling and a separate analysis of U.S. nutrition, allergen and claims requirements.
African Companies
Products entering the American market should be evaluated against U.S. regulatory classification and labeling requirements rather than relying solely on local-market compliance.
Importers and distributors should likewise avoid assuming that responsibility rests only with the foreign manufacturer. Noncompliant labeling can create practical problems at entry, during marketplace reviews, after FDA inspection or as the result of consumer complaints, competitor complaints or FDA surveillance.
Reviewing labels before commercial production is normally more efficient than correcting hundreds or thousands of finished packages after printing.
Chapter 11
Common FDA Labeling Problems
Wrong Facts Panel
Using Nutrition Facts where Supplement Facts applies, or treating an OTC drug as a conventional cosmetic.
Foreign Nutrition Format
Reusing a European, Asian or other foreign nutrition panel without converting it to applicable U.S. requirements.
Improper Disease Claims
Describing a food, supplement or conventional cosmetic as treating, curing or preventing disease.
FDA Approval Claims
Presenting establishment registration or product listing as proof of FDA approval or endorsement.
Missing Allergens
Failing to properly identify an applicable major food allergen in packaged-food labeling.
Ingredient Errors
Incorrect names, missing subingredients, improper order or inconsistency with the actual formulation.
Serving-Size Errors
Using a convenient marketing serving rather than the serving size required under applicable rules.
Missing Warnings
Omitting required warnings, cautions, directions or other material safety information.
Website Conflicts
Maintaining conservative packaging while making aggressive therapeutic claims on websites or social media.
Chapter 12
FDA Label Compliance Services Provided by U.S. FDA Consultants
An experienced U.S. FDA regulatory consultant can help domestic and foreign companies identify labeling problems before products are manufactured, exported, imported or offered for sale in the United States.
A label-compliance review should not simply proofread the artwork. The consultant may need to compare the package against the formulation, ingredient specifications, intended use, marketing claims, product classification and applicable FDA requirements.
Services May Include
- Nutrition Facts label review.
- Supplement Facts label review.
- Drug Facts label review.
- Ingredient declaration review.
- Food allergen review.
- Serving-size evaluation.
- Product claims review.
- Structure/function claim evaluation.
- OTC drug versus cosmetic classification review.
- FDA registration and approval wording review.
- Imported-product label review.
- Website and e-commerce claim review.
Conclusion
A Compliant Product Requires a Compliant Message
FDA compliance does not end when a facility is registered or when a product reaches a U.S. warehouse. The label remains one of the primary ways the product communicates its identity, composition, intended use and safety information to consumers and regulators.
Conventional foods, dietary supplements and OTC drugs each use distinct labeling systems. The Nutrition Facts, Supplement Facts and Drug Facts panels are not interchangeable. Likewise, claims permitted for one category may fundamentally change the regulatory status of another.
Businesses should also understand that FDA registration is not FDA endorsement. Possession of a registration number generally should not be presented as evidence that FDA has certified, recommended or approved a private manufacturer or product. The FDA logo likewise should not be used on commercial materials in a way that suggests official government endorsement.
For food and supplement businesses, therapeutic language deserves particular attention. Conventional foods and dietary supplements are not simply alternative drug categories. Disease diagnosis, treatment, cure and prevention claims can create drug-regulatory consequences even if the package describes the article as a “food,” “natural product,” “herbal supplement” or “nutraceutical.”
The same principle applies to cosmetics. Calling a preparation a cosmetic does not control its legal classification if its intended use, claims and promotional materials establish a therapeutic drug purpose.
Finally, companies should remember that misleading labeling can arise through omission. Required warnings, material facts, ingredient declarations, allergens and other information must be evaluated as carefully as headline marketing claims.
For domestic companies and manufacturers, exporters, importers and distributors throughout Europe, Asia, Latin America and Africa, a professional U.S. label review before manufacturing or shipping can significantly reduce the cost and disruption associated with redesigns, delayed entries, compliance concerns and product relabeling.
FDA LABEL COMPLIANCE SERVICE
Review Your Label Before Your Product Reaches the U.S. Market
Packaging that works in another country may not satisfy U.S. FDA requirements. A regulatory label review can help identify problems involving Nutrition Facts, Supplement Facts, Drug Facts, ingredients, allergens, warnings, claims, intended use and misleading references to FDA registration or approval.
U.S. FDA Consultants can assist domestic businesses and foreign manufacturers, exporters, importers and distributors with label review and compliance strategies before printing, shipping or placing FDA-regulated products into U.S. commerce.
Before Printing Your Label
- Confirm product classification.
- Review required facts panel.
- Verify ingredients and allergens.
- Check warnings and directions.
- Review all marketing claims.
- Remove misleading FDA approval representations.
- Review final artwork before production.


